Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Jim Cramer Warns Silver Is ‘Overvalued’ As Peter Brandt Explains Why Your ‘Supply Shortage’ Narrative Might Be Dead

by Rishabh Mishra | Jan 30, 2026 | General

Silver prices are retreating from a historic peak after two of the most prominent voices in finance issued a stark reality check to investors riding the white metal’s parabolic surge. The Peak And The Pivot On Jan. 29, silver reached a staggering all-time high...

Trump Declares National Emergency Over Cuba, Threatens Tariffs On Countries Supplying Oil

by Namrata Sen | Jan 30, 2026 | General

President Donald Trump has declared a national emergency through an executive order over Cuba on Thursday, citing the communist regime’s alleged alignment with “hostile” foreign powers like Russia, China, Iran, and terrorist groups like Hamas and Hezbollah. Trump...
Regeneron Pharmaceuticals Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Regeneron Pharmaceuticals Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

by Avi Kapoor | Jan 30, 2026 | General

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will release earnings results for its fourth quarter, before the opening bell on Friday, Jan. 30. Analysts expect the Tarrytown, New York-based company to report quarterly earnings at $10.74 per share, down from $12.07 per...
Trump’s Interest Rate Cap And An Activist Short-Seller Report Is Weighing Hard On This BNPL Stock: Momentum Score Nosedives

Trump’s Interest Rate Cap And An Activist Short-Seller Report Is Weighing Hard On This BNPL Stock: Momentum Score Nosedives

by Vishaal Sanjay | Jan 30, 2026 | General

Leading buy now, pay later service, Affirm Holdings Inc. (NASDAQ:AFRM) is off to a rough start in 2026, down 15% year-to-date, as sector-wide pressures, alongside company-specific setbacks weight on the stock. The pressure on the stock is now being reflected in its...
UnitedHealth Rival Humana Tops Valuation Metric As 26% YTD Plunge Creates Entry Point Amid Trump’s Proposed Medicare Rates

UnitedHealth Rival Humana Tops Valuation Metric As 26% YTD Plunge Creates Entry Point Amid Trump’s Proposed Medicare Rates

by Rishabh Mishra | Jan 30, 2026 | General

Humana Inc. (NYSE:HUM) has emerged as a top-ranked value play within the healthcare sector following its stock price’s sharp 26.64% year-to-date decline. Valuation Vs. Momentum After a significant sector-wide sell-off triggered by the Donald Trump...
« Older Entries
Next Entries »

Recent Posts

  • Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer
  • Shutdown Leaves TSA Staff Unpaid, Travel Delays Loom
  • Nvidia’s Huang To Skip India AI Impact Summit
  • Berkshire’s Abel Lauds Kraft Heinz Turnaround, Eyes Future Split
  • Rubio Urges Europe To Join Trump Security Strategy

Recent Comments

    Archives

    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.